- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03459677
Back2School - CBT Intervention for School Absenteeism (B2S)
Cognitive Behavioral Therapy Intervention for School Absenteeism: a Randomized Controlled Trial
The main objective of this study is to examine the efficacy of a new psychological intervention, called Back2School, in helping youths with problematic school absenteeism to return to school. Furthermore, the study will examine how well this program fares against the treatment or interventions that are usually given to youths with school absenteeism (treatment as usual or TAU).
Based on previous studies we hypothesize that the Back2School intervention will be better at improving levels of school attendance as compared with treatment as usual (TAU).
Study Overview
Status
Intervention / Treatment
Detailed Description
Primary objective The main objective of this study is to examine the efficacy on school attendance and wellbeing of a modular trans-diagnostic CBT intervention for youths with problematic school absenteeism in a randomized controlled trial. Based on previous studies we hypothesize that the B2S intervention will show a significant difference in impact for school attendance, in favor of Back2School intervention as compared with TAU
Trial design The study is a randomized controlled superiority trial (RCT) that compares a modular trans-diagnostic CBT intervention (Back2School), treating school absenteeism in youths aged 7-17 years with treatment as usual (TAU). The design will follow a two (Back2School and TAU) by four (Time: pre, post, 3-month, and 1-year assessment) mixed between-within design.
The study is a collaboration project between Aarhus University and Aarhus Municipality, Denmark. The setting for both the B2S and TAU interventions are within Aarhus municipality. The Back2School intervention is organized and conducted by the University Clinic, at Aarhus University. Treatment as usual interventions are organized and conducted by Aarhus Municipality.
There are considerable negative long-term consequences related to youths with school absenteeism. If the B2S intervention proves to be effective in reducing school absenteeism, it could be implemented in other municipalities in Denmark, and help to systematically treat and help youths with school absenteeism. This could possibly reduce both personal and societal costs significantly
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Århus, Denmark, 8000
- Aarhus University, Department of Psychology and Behavioural Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Youths are enrolled in a public school within the municipality of Aarhus.
- Aged 7-18 years and in 0-9th grade (excluding second semester of the 9th grade).
- Report more than 10% absenteeism during the last 3 months of school (excluding legal absence, e.g. permitted extra holidays).
- The youth and at least one of the two parents understand and speak Danish sufficiently to participate in treatment and complete questionnaires.
- At least one of the parents is motivated for working on increasing the youths' school attendance.
- The participating families are willing to participate in assessment, intervention procedures, and acceptance of random assignment to intervention.
- Written informed consent from the holders of the parental rights and responsibilities (usually both parents).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Back2School Condition
The Back2School condition is a Modular Trans-Diagnostic Cognitive Behavioral Therapy (MTCBT) treating school absenteeism in youths. The MTCBT intervention consist of 10 sessions and 4 school meetings, conducted over a period of 4 months. |
Modular Trans-diagnostic Cognitive Behavioral Therapy treating school absenteeism in youths
Other Names:
|
Active Comparator: Treatment As Usual Condition
The Treatment As Usual condition (TAU) consist of an array of interventions that the municipality is required to give youths presenting school absenteeism. The TAU condition will last for 4 months. |
Aarhus municipality's treatment as usual for youths presenting school absenteeism
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in School Attendance - Registry data
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
Aarhus Municipality's registry data of the youths' school attendance
|
Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
Change in School Attendance - Self-reported data
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
Self-reported school attendance in the previous two weeks, reported by parents.
|
Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Strength and Difficulties Questionnaire (SDQ)
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
The SDQ measures psychopathology in youths (3-16 years). There is a SDQ version for youths (SDQ), parents (SDQ-P), and teachers (SDQ-T). The different versions consist of the same items, and are scored identically. Total of 25 items, rated on a 3-point scale (0-2), divided into 5 sub-scales consisting of 5 items. Sub-scales: Emotional symptoms, Conduct problems, Hyperactivity/inattention, Peer relationships problems, Pro-social behavior For each sub-scale, minimum score is 0 and maximum total score is 10 The total score is computed by summing up the sub-scales, with the exception of the "pro-social behavior" sub-scale. Minimum total score is 0, and maximum total score is 40. The extended version of the SDQ includes an impact scale with additional 8 items, regarding child distress and interference. The Impact scale is scored on a 4-point scale (0-3). The impact scale is summed up by counting only scores of 2 or 3. Minimum score 0, and maximum score 24. |
Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
The Spence Children's Anxiety Scale (SCAS)
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
Self-report rating scale assessing youths symptoms of anxiety, rated by youths (SCAS) and parents (SCAS-P). Total of 38 items, rated on a 4-point scale (0-3), divided into 6 sub-scales. The SCAS includes 6 positive filler items not included in the computation of sub-scores or total score. Sub-scales: Social Phobia (6 items), Panic disorder and agoraphobia (9 items), Generalized anxiety disorder (6 items, range 0-18), Obsessive-compulsive disorder (6 items, range 0-18), separation anxiety disorder (6 items, range 0-18), Fear of physical injury (5 items, , range 0-15). Minimum total score is 0, and maximum total score is 114. The SCAS-P is identical to the SCAS in form an scoring, but does not include the 6 positive filler items. |
Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
The Mood and Feelings Questionnaire (MFQ)
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
Covers a broad range of cognitive and vegetative symptoms of depression in youths. There is both a youth (MFQ) and parent (MFQ-P) version of the MFQ. The MFQ consistTotal of 33 items, rated on a 3-point scale (0-2). The MFQ-P consist of 34 items. Both the scores for MFQ and MFQ-P are computed by summing up all items. Higher scores indicating more sever depressive symptoms. Minimum MFQ score is 0, maximum score is 66. Minimum MFQ-P score is 0, maximum score is 68. |
Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
The Child Health Utility 9D Index (CHU-9D)
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
Designed to determine how health affect youths's lives, rated by youths. Consist of 9 items, rated on a 5-point scale. Each item is related to a dimension to how the youths are feeling worried, sad, pain, tired, annoyed, schoolwork/ homework, sleep, daily routine, and participating in activities. Higher scores for each item is related to a higher perceived difficulty related to a dimension. Each dimension/item has a minimum score of 1, and a maximum score of 5. |
Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
The Self-efficacy Questionnaire for School Situations (SEQ-SS)
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
Measures self-efficacy expectations to different school situations, rated by youths. Consist of 12 items, rated on a 5-point scale (1-5), and divided into 2 sub-scales both consisting of 6 items. Minimum SEQ-SS score is 12, maximum score is 60. Higher scores reflect greater self-efficacy expectations. |
Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
Self-Efficacy Questionnaire for Responding to School Attendance Problems (SEQ-RSAP)
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
Measures parents self-efficacy expectations to different school situations, rated by parents. Consist of 13 items, rated on a 4-point scale (1-4). Minimum score is 13, and maximum score is 52. Higher scores reflect greater self-efficacy expectations in parents ability to help their child in different school situations. |
Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
The Family Assessment Device (FAD)
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
Assess different dimensions of family function, rated by youths (12 years and older) and parents. Only the sub-scale regarding General Function is used in this study. The sub-scale consist of 12 items, rated on a 4 point-scale (1-4). The FAD is scored by calculating the mean scores of all items. Higher means are related to a more unhealthy or non-functional family function. |
Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Experience of Service Questionnaire (ESQ)
Time Frame: Post-treatment (4-months), 3-months follow-up.
|
Assess the satisfaction with the treatment, rated by youths and parents. The treatment satisfaction for the youths consist of 7 items rated on a 3 point-scale (0-2), with 1 open question. Treatment satisfaction for parents is assessed using 10 items, rated on a 3-point-scale (0-2), with 3 open questions. Higher scores is associated with |
Post-treatment (4-months), 3-months follow-up.
|
Collaboration with the school
Time Frame: Post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
Assess the collaboration between the family and the school/teacher. Consist of 3 items rated on a 4-point scale (1-4). Higher scores are related to a good relationship and collaboration with the school. Both parents and teachers respond to this questionnaire. |
Post-treatment (4-months), 3-months follow-up, 12-months follow-up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mikael Thastum, Professor, Aarhus University, Department of Psychology and Behavioural Sciences
- Study Director: Johanne L Jeppesen, PhD, Aarhus University, Department of Psychology and Behavioural Sciences
- Study Director: Daniel B Johnsen, PhD Fellow, Aarhus University, Department of Psychology and Behavioural Sciences
Publications and helpful links
General Publications
- Johnsen DB, Lomholt JJ, Heyne D, Jeppesen P, Jensen MB, Silverman WK, Thastum M. Sociodemographic and clinical characteristics of youths and parents seeking psychological treatment for school attendance problems. PLoS One. 2022 Jan 26;17(1):e0261449. doi: 10.1371/journal.pone.0261449. eCollection 2022.
- Thastum M, Johnsen DB, Silverman WK, Jeppesen P, Heyne DA, Lomholt JJ. The Back2School modular cognitive behavioral intervention for youths with problematic school absenteeism: study protocol for a randomized controlled trial. Trials. 2019 Jan 8;20(1):29. doi: 10.1186/s13063-018-3124-3.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SPONSoR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Symptoms
-
Julia EderNot yet recruitingDepressive Disorder | Depression | Depressive Symptoms | Major Depressive Disorder | Depressive EpisodeGermany
-
Medical Research CouncilKU LeuvenCompletedDepressive Symptoms | Major Depressive DisorderAustralia
-
Massachusetts General HospitalCompletedMajor Depressive DisorderUnited States, China
-
Dr. Nazanin AlaviCompletedDepression | Depressive Symptoms | Major Depressive DisorderCanada
-
Linkoeping UniversityCompletedMajor Depressive DisorderSweden
-
The University of Texas Health Science Center at...TerminatedDepression | Major Depressive DisorderUnited States
-
Santa Casa Medical SchoolFaculdade de Ciências Médicas da Santa Casa de São PauloUnknownDepressive SymptomsBrazil
-
State University of New York at BuffaloCompletedDepressive Symptoms | Major Depressive Disorder, Recurrent, in RemissionUnited States
-
University of TorontoKaiser Permanente; University of Colorado, BoulderCompletedDepressive Symptoms | Major Depressive Disorder, Recurrent, in RemissionUnited States
-
University of PittsburghCompleted